No Data
Ocumension Therapeutics-B (01477.HK) spent 1.05 million Hong Kong dollars to repurchase 0.2 million shares on November 22.
Greenwich Daily News November 22nd | Eucon Medical Vision-B (01477.HK) announced that on November 22nd, it spent 1.05 million Hong Kong dollars to repurchase 0.2 million shares.
Private Equity Firms Who Own 30% Along With Institutions Invested in Ocumension Therapeutics (HKG:1477) Saw Increase in Their Holdings Value Last Week
EuKangweiVisionBio-B (01477) spent approximately 0.0778 million Hong Kong dollars to repurchase 0.0145 million shares on November 20.
Ocuvision Biology-B (01477) announced that on November 20, 2024, it will spend approximately 0.0778 million Hong Kong dollars to repurchase...
Eucan Vision Bio-B (01477) spent HKD 0.2679 million on November 18 to buy back 0.0525 million shares.
Eucan Vision Bio-B (01477) announced that on November 18, 2024, the company invested 26....
Ocumension Therapeutics-B (01477.HK) spent 0.202 million Hong Kong dollars on repurchasing 0.0355 million shares on October 25th.
Glory Horizons reported on October 25th that Eurocell Bio-B (01477.HK) announced that on October 25, 2024, they spent 0.202 million Hong Kong dollars to repurchase 0.0355 million shares at a repurchase price of 5.67-5.84 Hong Kong dollars per share.
Ocuvision Biotech-B (01477.HK): Wang Yumeng resigns as a non-executive director.
On October 21st, Bio-Gene Technology Limited (01477.HK) announced that Ms. Wang Yumeng has resigned as a non-executive director on the date of this announcement in order to focus on other work, with her resignation taking immediate effect.
Companies Like Ocumension Therapeutics (HKG:1477) Are In A Position To Invest In GrowthNo Data
No Data
